One connector, four scholarly indexes, real DOIs and legal free PDFs. Works in Claude and ChatGPT.
Paste it into Claude or ChatGPT as a custom connector. 3-day free trial.
Lei Miao, Yu Zhang, Leaf Huang
mRNA vaccines have become a promising platform for cancer immunotherapy. During vaccination, naked or vehicle loaded mRNA vaccines efficiently express tumor antigens in antigen-presenting cells (APCs), facilitate APC activation and innate/adaptive immune stimulation. mRNA cancer vaccine precedes other conventional vaccine platforms due to high potency, safe administration, rapid development potentials, and cost-effective manufacturing. However, mRNA vaccine applications have been limited by instability, innate immunogenicity, and inefficient in vivo delivery. Appropriate mRNA structure modifications (i.e., codon optimizations, nucleotide modifications, self-amplifying mRNAs, etc.) and formulation methods (i.e., lipid nanoparticles (LNPs), polymers, peptides, etc.) have been investigated to overcome these issues. Tuning the administration routes and co-delivery of multiple mRNA vaccines with other immunotherapeutic agents (e.g., checkpoint inhibitors) have further boosted the host anti-tumor immunity and increased the likelihood of tumor cell eradication. With the recent U.S. Food and Drug Administration (FDA) approvals of LNP-loaded mRNA vaccines for the prevention of COVID-19 and the promising therapeutic outcomes of mRNA cancer vaccines achieved in several clinical trials against multiple aggressive solid tumors, we envision the rapid advancing of mRNA vaccines for cancer immunotherapy in the near future. This review provides a detailed overview of the recent progress and existing challenges of mRNA cancer vaccines and future considerations of applying mRNA vaccine for cancer immunotherapies.
Formatted from the source metadata, not typed by hand. For a whole reference list, use the citation generator or ask your assistant through Find Research.
Miao, L., Zhang, Y., & Huang, L. (2021). mRNA vaccine for cancer immunotherapy. Molecular Cancer, 20(1), 41. https://doi.org/10.1186/s12943-021-01335-5
Miao, Lei, et al. "mRNA vaccine for cancer immunotherapy." Molecular Cancer, vol. 20, no. 1, 2021, pp. 41, https://doi.org/10.1186/s12943-021-01335-5.
Miao, Lei, Yu Zhang, and Leaf Huang. "mRNA vaccine for cancer immunotherapy." Molecular Cancer 20, no. 1 (2021): 41. https://doi.org/10.1186/s12943-021-01335-5.
Miao L., Zhang Y., Huang L. mRNA vaccine for cancer immunotherapy // Molecular Cancer. — 2021. — Vol. 20, № 1. — P. 41. — URL: https://doi.org/10.1186/s12943-021-01335-5
@article{miao2021mrna,
title = {{mRNA vaccine for cancer immunotherapy}},
author = {Lei Miao and Yu Zhang and Leaf Huang},
journal = {Molecular Cancer},
year = {2021},
volume = {20},
number = {1},
pages = {41},
doi = {10.1186/s12943-021-01335-5},
url = {https://doi.org/10.1186/s12943-021-01335-5}
}TY - JOUR AU - Miao, Lei AU - Zhang, Yu AU - Huang, Leaf TI - mRNA vaccine for cancer immunotherapy JO - Molecular Cancer VL - 20 IS - 1 SP - 41 PY - 2021 DA - 2021/02/25 DO - 10.1186/s12943-021-01335-5 UR - https://doi.org/10.1186/s12943-021-01335-5 ER -
Add Find Research to Claude or ChatGPT and ask in plain language. The assistant reads this record, finds the papers around it and cites only what it actually found:
Setup takes about a minute: add the connector, then start the free trial.
Record from OpenAlex; open-access location from Unpaywall and the indexes. Find Research links only to legal copies.